Warning: fopen(/home/virtual/jptm/journal/upload/ip_log/ip_log_2022-11.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 83 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 Journal of Pathology and Translational Medicine
Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Pathol Transl Med > Volume 44(4); 2010 > Article
Original Article Mutation and Expression of DNA2 Gene in Gastric and Colorectal Carcinomas.
Sung Hak Lee, Yoo Ri Kim, Nam Jin Yoo, Sug Hyung Lee
Journal of Pathology and Translational Medicine 2010;44(4):354-359
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.4.354
  • 3,007 Views
  • 21 Download
  • 3 Crossref
  • 4 Scopus
1Department of Hospital Pathology, The Catholic University of Korea College of Medicine, Seoul, Korea.
2Department of Pathology, The Catholic University of Korea College of Medicine, Seoul, Korea. suhulee@catholic.ac.kr

BACKGROUND
Deregulation of DNA repair and replication are involved in cancer development. DNA2 is a nuclease/helicase that plays roles in DNA repair and replication. The aim of this study was to explore DNA2 mutation and DNA2 protein expression in gastric cancers (GCs) and colorectal cancers (CRCs).
METHODS
We analyzed two mononucleotide repeats in DNA2 in 27 GCs with high microsatellite instability (MSI-H), 34 GCs with stable MSI (MSS), 29 CRCs with MSI-H and 35 CRCs with MSS by single-strand conformation polymorphism. We also analyzed DNA2 expression in GCs and CRCs either with MSI-H or MSS.
RESULTS
We found DNA2 mutations in two GCs (7.1%) and two CRCs with MSI-H (6.9%), but not in cancers with MSS. The mutations consisted of three cases of a c.2593delT and one of a c.2592_2593delTT, which would result in premature stopping of amino acid synthesis (p.Ser865Hisfsx6 and p.Ser865Thrfsx20, respectively). DNA2 expression was observed in 16 (80%) of the GCs and 15 (75%) of the CRCs with MSI-H, but all of the cancers with DNA2 frameshift mutations were weak or negative for DNA2.
CONCLUSIONS
Our data indicate that DNA2 mutation and loss of DNA2 expression occur in GCs and CRCs, and suggest that these alterations may contribute to cancer pathogenesis by deregulating DNA repair and replication.

Related articles

JPTM : Journal of Pathology and Translational Medicine